title: Response to "Disparities in the use of chemotherapy and monoclonal antibody therapy for elderly advanced colorectal cancer patients in the community oncology setting".
authors.forename: Maggie
authors.initials: M
authors.lastname: Moore
authors.forename: Suzanne
authors.initials: S
authors.lastname: Kosmider
authors.forename: Kathryn
authors.initials: K
authors.lastname: Field
authors.forename: Jayesh
authors.initials: J
authors.lastname: Desai
authors.forename: Lionel
authors.initials: L
authors.lastname: Lim
authors.forename: Frances
authors.initials: F
authors.lastname: Barnett
authors.forename: Peter
authors.initials: P
authors.lastname: Gibbs
mesh_terms: D000367:Age Factors; D000368:Aged; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D006801:Humans; D015996:Survival Rate
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents